China SXT Pharmaceuticals (SXTC) Inventory Average (2018 - 2025)
Historic Inventory Average for China SXT Pharmaceuticals (SXTC) over the last 8 years, with Q3 2025 value amounting to $789699.5.
- China SXT Pharmaceuticals' Inventory Average fell 497.5% to $789699.5 in Q3 2025 from the same period last year, while for Sep 2025 it was $789699.5, marking a year-over-year decrease of 497.5%. This contributed to the annual value of $811454.0 for FY2025, which is 2238.12% up from last year.
- Latest data reveals that China SXT Pharmaceuticals reported Inventory Average of $789699.5 as of Q3 2025, which was down 497.5% from $847643.0 recorded in Q1 2025.
- Over the past 5 years, China SXT Pharmaceuticals' Inventory Average peaked at $927487.0 during Q1 2022, and registered a low of $512234.0 during Q3 2023.
- Over the past 5 years, China SXT Pharmaceuticals' median Inventory Average value was $826950.2 (recorded in 2022), while the average stood at $766677.8.
- Its Inventory Average has fluctuated over the past 5 years, first crashed by 3774.93% in 2023, then skyrocketed by 6223.91% in 2024.
- Over the past 5 years, China SXT Pharmaceuticals' Inventory Average (Quarter) stood at $848571.5 in 2021, then dropped by 3.03% to $822856.5 in 2022, then plummeted by 37.75% to $512234.0 in 2023, then surged by 62.24% to $831044.0 in 2024, then fell by 4.98% to $789699.5 in 2025.
- Its last three reported values are $789699.5 in Q3 2025, $847643.0 for Q1 2025, and $831044.0 during Q3 2024.